The following is a summary of “Tebentafusp Induces a T-Cell–Driven Rash in Melanocyte-Bearing Skin as an Adverse Event Consistent with the Mechanism of Action,” published in the March 2025 issue of Journal of Investigative Dermatology by Hassel et al. Researchers conducted a retrospective study to investigate the mechanism of skin-related adverse events (SRAE), particularly rash, […]
The post Immunologic Basis of Skin Rash in Tebentafusp Treatment first appeared on Physician’s Weekly.
